Mark Harvill

Mark has held leadership positions in global contract research organizations (CROs) for the past 25 years, overseeing industry-leading client-relationships and supporting the development of numerous blockbuster drugs and medical devices, including three of the world’s top-selling drugs. As CEO of Avomeen, Mark fosters a positive and collaborative culture, championing Avomeen’s scientific team in harmony with our clients. He works closely with the senior leadership and project teams to ensure the company delivers on its promise to be an innovative and tenacious partner with exceptional client service, while ensuring compliance with rigorous regulatory standards.